{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:54:40Z","timestamp":1785837280125,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Cape Town"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>In resource-limited environments, setting priorities for leukemia care becomes essential to ensure effective and efficient use of available resources. This study aimed to identify the key areas of leukemia care and services by determining their prioritization within the South African healthcare system and developing a set of improvement and research priorities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A two-round modified Delphi method was used to identify leukemia care priorities and rank areas of leukemia management improvement and research priorities. Healthcare professional experts comprised of Clinical Hematologists and Hematopathologists. In round 1, participants independently rated the importance of 125 iterative statements on leukemia care and services derived from literature. In round 2, agreement within the expert participants was considered to finalize the list of priority statements and 17 improvement and research priorities were ranked based on level of importance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, a list of 67 priority statements reached consensus, and 17 improvement and research priorities were established. A high agreement (\u2265\u200990%) was reached for 24 statements within the six themes, these included accurate and advanced diagnostic techniques, factors in determining treatment strategies (e.g., risk stratification), supportive care measures (e.g., pain management and infection prevention), ensuring adequate healthcare workforce, and creating multidisciplinary teams. The highest ranked improvement and research priorities were timely delivery of diagnosis and treatments and biomarker development for early detection, prognosis, and treatment response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study identified key priorities for leukemia care within the South African healthcare system, providing an evidence-based framework through expert consensus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10552-025-01979-4","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:24:47Z","timestamp":1741101887000},"page":"781-793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Priority setting for improved leukemia management and research in South Africa: a modified Delphi study"],"prefix":"10.1007","volume":"36","author":[{"given":"Rochelle","family":"Woudberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina","family":"Sinanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"3","key":"1979_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"1979_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.598215","volume":"8","author":"B Li","year":"2020","unstructured":"Li B et al (2020) The current situation and future trend of leukemia mortality by sex and area in China. Front Public Health 8:598215","journal-title":"Front Public Health"},{"key":"1979_CR3","unstructured":"GHDx (2021) GBD results tool"},{"issue":"7","key":"1979_CR4","first-page":"436","volume":"31","author":"VM Yenson","year":"2023","unstructured":"Yenson VM et al (2023) Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian\/New Zealand modified Delphi study. Support Care Cancer 31(7):436","journal-title":"Support Care Cancer"},{"issue":"3","key":"1979_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.seminhematol.2013.06.007","volume":"50","author":"CH Pui","year":"2013","unstructured":"Pui CH, Evans WE (2013) A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol 50(3):185\u2013196","journal-title":"Semin Hematol"},{"issue":"4","key":"1979_CR6","first-page":"316","volume":"9","author":"Y Veisani","year":"2018","unstructured":"Veisani Y, Khazaei S, Delpisheh A (2018) 5-year survival rates based on the type of leukemia in Iran, a Meta-analysis. Caspian J Intern Med 9(4):316\u2013324","journal-title":"Caspian J Intern Med"},{"issue":"5","key":"1979_CR7","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41375-021-01238-w","volume":"35","author":"Y-C Hsieh","year":"2021","unstructured":"Hsieh Y-C, Kirschner K, Copland M (2021) Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape. Leukemia 35(5):1229\u20131242","journal-title":"Leukemia"},{"issue":"1","key":"1979_CR8","volume":"16","author":"A Iqbal","year":"2024","unstructured":"Iqbal A et al (2024) Improved treatment outcomes with modified induction therapy in acute myeloid leukemia (AML): a retrospective observational study from a regional cancer center. Cureus 16(1):e53303","journal-title":"Cureus"},{"issue":"8","key":"1979_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/MPH.0000000000000653","volume":"38","author":"K Jabeen","year":"2016","unstructured":"Jabeen K et al (2016) The impact of socioeconomic factors on the outcome of childhood acute lymphoblastic leukemia (ALL) treatment in a low\/middle income country (LMIC). J Pediatr Hematol Oncol 38(8):587\u2013596","journal-title":"J Pediatr Hematol Oncol"},{"issue":"13","key":"1979_CR10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/jnci\/djp148","volume":"101","author":"GT Armstrong","year":"2009","unstructured":"Armstrong GT et al (2009) Long-term outcomes among adult survivors of childhood central nervous system malignancies in the childhood cancer survivor study. JNCI: J Natl Cancer Instit 101(13):946\u2013958","journal-title":"JNCI: J Natl Cancer Instit"},{"key":"1979_CR11","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00123","volume":"9","author":"P Aristizabal","year":"2023","unstructured":"Aristizabal P et al (2023) Childhood leukemia survival in the US-Mexico border: building sustainable leukemia care using health systems strengthening models. JCO Glob Oncol 9:e2300123","journal-title":"JCO Glob Oncol"},{"issue":"4","key":"1979_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.14740\/wjon1277","volume":"11","author":"I Bou Akl","year":"2020","unstructured":"Bou Akl I et al (2020) Current status and future perspectives of immunotherapy in middle-income countries: a single-center early experience. World J Oncol 11(4):150\u2013157","journal-title":"World J Oncol"},{"key":"1979_CR13","doi-asserted-by":"crossref","unstructured":"Rujkijyanont P, Inaba H (2024) Diagnostic and treatment strategies for pediatric acute lymphoblastic leukemia in low- and middle-income countries. Leukemia","DOI":"10.1038\/s41375-024-02277-9"},{"key":"1979_CR14","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2147\/CMAR.S362882","volume":"14","author":"B Rugwizangoga","year":"2022","unstructured":"Rugwizangoga B et al (2022) Experience and perception of patients and healthcare professionals on acute leukemia in Rwanda: a qualitative study. Cancer Manag Res 14:1923\u20131934","journal-title":"Cancer Manag Res"},{"issue":"12","key":"1979_CR15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1200\/JCO.20.02602","volume":"39","author":"JM Unger","year":"2021","unstructured":"Unger JM et al (2021) Persistent disparity: socioeconomic deprivation and cancer outcomes in patients treated in clinical trials. J Clin Oncol 39(12):1339\u20131348","journal-title":"J Clin Oncol"},{"key":"1979_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-pathol-042320-034052","volume":"17","author":"JP Radich","year":"2022","unstructured":"Radich JP et al (2022) Precision medicine in low- and middle-income countries. Annu Rev Pathol 17:387\u2013402","journal-title":"Annu Rev Pathol"},{"key":"1979_CR17","unstructured":"Nations U (2015) Sustainable development goals. https:\/\/www.un.org\/sustainabledevelopment\/sustainable-development-goals\/."},{"issue":"4","key":"1979_CR18","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3390\/ijerph19041918","volume":"19","author":"B Lubuzo","year":"2022","unstructured":"Lubuzo B, Hlongwana KW, Ginindza TG (2022) Improving timely access to diagnostic and treatment services for lung cancer patients in KwaZulu-Natal, South Africa: priority-setting through nominal group techniques. Int J Environ Res Public Health 19(4):1918","journal-title":"Int J Environ Res Public Health"},{"key":"1979_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.breast.2020.09.012","volume":"54","author":"S Nietz","year":"2020","unstructured":"Nietz S et al (2020) Quality indicators for the diagnosis and surgical management of breast cancer in South Africa. Breast 54:187\u2013196","journal-title":"Breast"},{"key":"1979_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.596682","volume":"12","author":"J Shaw","year":"2021","unstructured":"Shaw J et al (2021) Setting an international research agenda for fear of cancer recurrence: an online Delphi consensus study. Front Psychol 12:596682","journal-title":"Front Psychol"},{"issue":"10","key":"1979_CR21","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/cancers13102299","volume":"13","author":"K Lisy","year":"2021","unstructured":"Lisy K et al (2021) How do we define and measure optimal care for cancer survivors? An online modified reactive Delphi study. Cancers 13(10):2299","journal-title":"Cancers"},{"issue":"1","key":"1979_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12954-022-00650-4","volume":"19","author":"M Ferguson","year":"2022","unstructured":"Ferguson M et al (2022) Priority setting for Canadian take-home naloxone best practice guideline development: an adapted online Delphi method. Harm Reduct J 19(1):71","journal-title":"Harm Reduct J"},{"issue":"1","key":"1979_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12961-024-01133-7","volume":"22","author":"S Durao","year":"2024","unstructured":"Durao S et al (2024) Using a priority setting exercise to identify priorities for guidelines on new born and child health in South Africa, Malawi, and Nigeria. Health Res Policy Syst 22(1):48","journal-title":"Health Res Policy Syst"},{"issue":"8","key":"1979_CR24","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/0269216317690685","volume":"31","author":"S Junger","year":"2017","unstructured":"Junger S et al (2017) Guidance on conducting and reporting Delphi studies (CREDES) in palliative care: recommendations based on a methodological systematic review. Palliat Med 31(8):684\u2013706","journal-title":"Palliat Med"},{"issue":"4","key":"1979_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.eujim.2015.07.002","volume":"7","author":"EG Trevelyan","year":"2015","unstructured":"Trevelyan EG, Robinson PN (2015) Delphi methodology in health research: how to do it? Eur J Integr Med 7(4):423\u2013428","journal-title":"Eur J Integr Med"},{"issue":"6","key":"1979_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2648.1987.tb01376.x","volume":"12","author":"CM Goodman","year":"1987","unstructured":"Goodman CM (1987) The Delphi technique: a critique. J Adv Nurs 12(6):729\u2013734","journal-title":"J Adv Nurs"},{"issue":"1","key":"1979_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11764-021-01135-2","volume":"16","author":"C Mazariego","year":"2022","unstructured":"Mazariego C et al (2022) Priority recommendations for the implementation of patient-reported outcomes in clinical cancer care: a Delphi study. J Cancer Surviv 16(1):33\u201343","journal-title":"J Cancer Surviv"},{"issue":"6","key":"1979_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101116","volume":"26","author":"Z Fehlberg","year":"2024","unstructured":"Fehlberg Z et al (2024) Determining priority indicators of utility for genomic testing in rare disease: a Delphi study. Genet Med 26(6):101116","journal-title":"Genet Med"},{"issue":"1","key":"1979_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1108\/14777260310469319","volume":"17","author":"PM Mullen","year":"2003","unstructured":"Mullen PM (2003) Delphi: myths and reality. J Health Organ Manag 17(1):37\u201352","journal-title":"J Health Organ Manag"},{"issue":"1","key":"1979_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.im.2003.11.002","volume":"42","author":"C Okoli","year":"2004","unstructured":"Okoli C, Pawlowski SD (2004) The Delphi method as a research tool: an example, design considerations and applications. Information & Management 42(1):15\u201329","journal-title":"Information & Management"},{"key":"1979_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4103\/jehp.jehp_1550_21","volume":"11","author":"S Sayahi","year":"2022","unstructured":"Sayahi S et al (2022) A modified Delphi study to identify strategies to promote health literacy in parents of children with cancer. J Educ Health Promot 11:370","journal-title":"J Educ Health Promot"},{"key":"1979_CR32","doi-asserted-by":"publisher","DOI":"10.7275\/pdz9-th90","author":"C-C Hsu","year":"2007","unstructured":"Hsu C-C, Sandford BA (2007) The Delphi technique: making sense of consensus. Pract Assess Res Eval. https:\/\/doi.org\/10.7275\/pdz9-th90","journal-title":"Pract Assess Res Eval"},{"issue":"3","key":"1979_CR33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1540-5915.1997.tb01330.x","volume":"28","author":"RC Schmidt","year":"1997","unstructured":"Schmidt RC (1997) Managing Delphi surveys using nonparametric statistical techniques. Decision Sci 28(3):763\u2013774","journal-title":"Decision Sci"},{"issue":"6","key":"1979_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s13312-020-1855-1","volume":"57","author":"S Agrwal","year":"2020","unstructured":"Agrwal S, Sahi PK (2020) National comprehensive cancer network guidelines for pediatric acute lymphoblastic leukemia. Indian Pediatr 57(6):561\u2013564","journal-title":"Indian Pediatr"},{"issue":"9","key":"1979_CR35","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","volume":"19","author":"PA Brown","year":"2021","unstructured":"Brown PA et al (2021) Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19(9):1079\u20131109","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"1979_CR36","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.6004\/jnccn.2020.0047","volume":"18","author":"MW Deininger","year":"2020","unstructured":"Deininger MW et al (2020) Chronic myeloid leukemia, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18(10):1385\u20131415","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"1979_CR37","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345\u20131377","journal-title":"Blood"},{"issue":"9","key":"1979_CR38","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/eat.23330","volume":"53","author":"CM McMaster","year":"2020","unstructured":"McMaster CM et al (2020) Development of consensus-based guidelines for outpatient dietetic treatment of eating disorders: a Delphi study. Int J Eat Disord 53(9):1480\u20131495","journal-title":"Int J Eat Disord"},{"issue":"4","key":"1979_CR39","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1046\/j.1365-2648.2000.t01-1-01569.x","volume":"32","author":"J Greatorex","year":"2000","unstructured":"Greatorex J, Dexter T (2000) An accessible analytical approach for investigating what happens between the rounds of a Delphi study. J Adv Nurs 32(4):1016\u20131024","journal-title":"J Adv Nurs"},{"issue":"12","key":"1979_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12183","volume":"8","author":"X Xu","year":"2022","unstructured":"Xu X et al (2022) A modified Delphi study on establishing a curriculum content structure for the leadership and management competency cultivation for future nurse managers in China. Heliyon 8(12):e12183","journal-title":"Heliyon"},{"issue":"4","key":"1979_CR41","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/eje.12902","volume":"27","author":"C Orsini","year":"2023","unstructured":"Orsini C et al (2023) The development of a reporting form for peer observation of online learning courses: an e-Delphi consensus study of educators working in health professions education. Eur J Dent Educ 27(4):1088\u20131097","journal-title":"Eur J Dent Educ"},{"issue":"1","key":"1979_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12874-019-0886-6","volume":"20","author":"T Woodcock","year":"2020","unstructured":"Woodcock T et al (2020) A modified Delphi study to identify the features of high quality measurement plans for healthcare improvement projects. BMC Med Res Methodol 20(1):8","journal-title":"BMC Med Res Methodol"},{"key":"1979_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43477-023-00087-2","volume":"3","author":"K Singh","year":"2023","unstructured":"Singh K et al (2023) A Delphi study to prioritize evidence-based strategies for cardiovascular disease care in India. Glob Implement Res Appl 3:1\u201312","journal-title":"Glob Implement Res Appl"},{"issue":"8","key":"1979_CR44","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.techfore.2013.01.003","volume":"80","author":"JV Meijering","year":"2013","unstructured":"Meijering JV, Kampen JK, Tobi H (2013) Quantifying the development of agreement among experts in Delphi studies. Technol Forecast Soc Chang 80(8):1607\u20131614","journal-title":"Technol Forecast Soc Chang"},{"issue":"10","key":"1979_CR45","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1634\/theoncologist.2019-0261","volume":"24","author":"SJ Nass","year":"2019","unstructured":"Nass SJ et al (2019) Improving cancer diagnosis and care: patient access to high-quality oncologic pathology. Oncologist 24(10):1287\u20131290","journal-title":"Oncologist"},{"key":"1979_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09547-8","author":"L Ding","year":"2022","unstructured":"Ding L et al (2022) Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-022-09547-8","journal-title":"BMC Cancer"},{"key":"1979_CR47","doi-asserted-by":"publisher","first-page":"204062072095500","DOI":"10.1177\/2040620720955002","volume":"11","author":"P Goswami","year":"2020","unstructured":"Goswami P et al (2020) Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study. Ther Adv Hematol 11:2040620720955002","journal-title":"Ther Adv Hematol"},{"key":"1979_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01454-5","author":"Y Jie","year":"2020","unstructured":"Jie Y et al (2020) Unmet supportive care needs and its relation to quality of life among adult acute leukaemia patients in China: a cross-sectional study. Health Quality Life Outcomes. https:\/\/doi.org\/10.1186\/s12955-020-01454-5","journal-title":"Health Quality Life Outcomes"},{"key":"1979_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2021-002898","author":"L Potenza","year":"2021","unstructured":"Potenza L et al (2021) Early palliative\/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: observational outpatient study. BMJ Support Palliat Care. https:\/\/doi.org\/10.1136\/bmjspcare-2021-002898","journal-title":"BMJ Support Palliat Care"},{"key":"1979_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1200\/EDBK_236857","volume":"39","author":"P Selby","year":"2019","unstructured":"Selby P et al (2019) The value and future developments of multidisciplinary team cancer care. Am Soc Clin Oncol Educ Book 39:332\u2013340","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"12","key":"1979_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11912-020-00987-8","volume":"22","author":"LA Meillon-Garcia","year":"2020","unstructured":"Meillon-Garcia LA, Demichelis-Gomez R (2020) Access to therapy for acute myeloid leukemia in the developing world: barriers and solutions. Curr Oncol Rep 22(12):125","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"1979_CR52","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1057\/s41599-021-00940-5","volume":"8","author":"EK dos Santos Silva","year":"2021","unstructured":"dos Santos Silva EK et al (2021) Cost-effectiveness in health: consolidated research and contemporary challenges. Human Soc Sci Commun 8(1):254","journal-title":"Human Soc Sci Commun"},{"issue":"1","key":"1979_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","volume":"31","author":"J Prada-Arismendy","year":"2017","unstructured":"Prada-Arismendy J, Arroyave JC, R\u00f6thlisberger S (2017) Molecular biomarkers in acute myeloid leukemia. Blood Rev 31(1):63\u201376","journal-title":"Blood Rev"},{"issue":"1","key":"1979_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1182\/hematology.2023000504","volume":"2023","author":"C R\u00f6llig","year":"2023","unstructured":"R\u00f6llig C (2023) Improving long-term outcomes with intensive induction chemotherapy for patients with AML. Hematology 2023(1):175\u2013185","journal-title":"Hematology"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-01979-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-01979-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-01979-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:30:08Z","timestamp":1757143808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-01979-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1979"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-01979-4","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the University of Cape Town (UCT) Human Research Ethics Committee (923\/2023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Participation in this study was voluntary. Participants were provided with detailed information in the participation information sheet so that they could make an informed decision and informed consent was obtained prior to participating in each round of the Delphi study. Responses will not be traced back to the participants and no personally identifiable information was captured. Participants were not asked to indicate which organization or institute they represented.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Participants signed informed consent regarding publishing any data collected from this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}